Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 29 studies | 33% ± 13% | |
pericyte | 15 studies | 38% ± 19% | |
capillary endothelial cell | 14 studies | 40% ± 17% | |
fibroblast | 9 studies | 20% ± 4% | |
endothelial cell of lymphatic vessel | 8 studies | 23% ± 6% | |
endothelial cell of artery | 8 studies | 28% ± 11% | |
endothelial cell of vascular tree | 8 studies | 27% ± 18% | |
vein endothelial cell | 7 studies | 24% ± 11% | |
naive thymus-derived CD4-positive, alpha-beta T cell | 4 studies | 21% ± 3% | |
glomerular endothelial cell | 4 studies | 76% ± 7% | |
smooth muscle cell | 4 studies | 23% ± 5% | |
naive thymus-derived CD8-positive, alpha-beta T cell | 3 studies | 21% ± 5% | |
connective tissue cell | 3 studies | 19% ± 4% |
Insufficient scRNA-seq data for expression of TMEM204 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 4736.05 | 653 / 653 | 99% | 71.17 | 601 / 605 |
prostate | 99% | 2657.40 | 243 / 245 | 98% | 42.98 | 493 / 502 |
breast | 100% | 3887.74 | 459 / 459 | 97% | 39.46 | 1085 / 1118 |
adrenal gland | 100% | 1711.58 | 257 / 258 | 97% | 55.73 | 222 / 230 |
lung | 99% | 6637.14 | 575 / 578 | 94% | 25.47 | 1081 / 1155 |
bladder | 100% | 2575.14 | 21 / 21 | 90% | 23.70 | 454 / 504 |
intestine | 99% | 2264.15 | 958 / 966 | 90% | 22.54 | 475 / 527 |
skin | 96% | 1906.21 | 1745 / 1809 | 90% | 45.88 | 427 / 472 |
stomach | 94% | 1604.05 | 337 / 359 | 92% | 25.84 | 262 / 286 |
kidney | 100% | 3500.63 | 89 / 89 | 85% | 78.35 | 764 / 901 |
uterus | 100% | 3205.39 | 170 / 170 | 82% | 20.95 | 378 / 459 |
esophagus | 93% | 2226.04 | 1347 / 1445 | 87% | 17.11 | 159 / 183 |
pancreas | 76% | 706.77 | 250 / 328 | 99% | 74.14 | 176 / 178 |
ovary | 99% | 1505.18 | 179 / 180 | 61% | 9.01 | 262 / 430 |
liver | 69% | 684.81 | 156 / 226 | 82% | 20.17 | 332 / 406 |
brain | 52% | 469.79 | 1379 / 2642 | 99% | 33.67 | 695 / 705 |
adipose | 100% | 4310.21 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 2147.40 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 12.07 | 1 / 1 |
blood vessel | 100% | 4323.68 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 100% | 2719.01 | 859 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 51.62 | 78 / 80 |
tonsil | 0% | 0 | 0 / 0 | 93% | 21.62 | 42 / 45 |
lymph node | 0% | 0 | 0 / 0 | 93% | 20.18 | 27 / 29 |
muscle | 80% | 840.34 | 644 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 22% | 202.88 | 206 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001945 | Biological process | lymph vessel development |
GO_0051145 | Biological process | smooth muscle cell differentiation |
GO_0030947 | Biological process | regulation of vascular endothelial growth factor receptor signaling pathway |
GO_0005912 | Cellular component | adherens junction |
GO_0005886 | Cellular component | plasma membrane |
Gene name | TMEM204 |
Protein name | Transmembrane protein 204 (Claudin-like protein 24) |
Synonyms | C16orf30 UNQ6509/PRO21434 CLP24 |
Description | FUNCTION: Can influence paracellular permeability. Appears to be involved in cell-cell interactions through adherens. |
Accessions | ENST00000566264.2 Q9BSN7 ENST00000253934.9 |